Template:Hyperlipoproteinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|- | |- | ||
|- bgcolor="LightGrey" | |||
! | |||
[[Hyperlipoproteinemia|Hyperlipoproteinemia Main Page]] | |||
|- | |||
! | |||
|- | |||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
Line 11: | Line 17: | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
|- bgcolor="Pink" | |- bgcolor="Pink" |
Revision as of 15:39, 2 March 2017
Hyperlipoproteinemia Microchapters |
Primary Hyperlipoprotein Disorders: |
|
|
|
|
|
|
|
ACC/AHA Guideline Recommendations |
Intensity of statin therapy in primary and secondary prevention |